Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy | Eye
3-year follow-up of half-dose verteporfin photodynamic therapy for central serous chorioretinopathy with OCT-angiography detected choroidal neovascularization | Scientific Reports
Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy - Ophthalmology
Five emerging treatments show mixed results
Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy | British Journal of Ophthalmology
Half-dose photodynamic therapy for serous non-neovascular retinal pigm | OPTH
Crossover to Half-dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy patients (SPECS) - ScienceDirect
Crossover to Half-Dose Photodynamic Therapy or Eplerenone in Chronic Central Serous Chorioretinopathy Patients - Ophthalmology Retina
APAO 2017 - Yellow Subthreshold Laser vs PDT in Eyes with Chronic Central Serous Chorioretinopathy - YouTube
Half-dose photodynamic therapy for serous non-neovascular retinal pigm | OPTH
Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial - American Journal of Ophthalmology
Quantitative evaluation of damage to retinal capillaries caused by half-dose and half-time photodynamic therapy with optical coherent tomographic angiography - ScienceDirect
Outcome of half-dose photodynamic therapy in chronic central serous chorioretinopathy with fovea-involving atrophy | SpringerLink
Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: A 3-year follow-up study | PLOS ONE
Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy | PLOS ONE
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopath
Crossover to Photodynamic Therapy or Micropulse Laser After Failure of Primary Treatment of Chronic Central Serous Chorioretinopathy: The REPLACE Trial - American Journal of Ophthalmology
Half-dose Versus Half-time Photodynamic Therapy for Central Serous Chorioretinopathy. | Semantic Scholar
Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: results of the Pan-American Collaborative Retina Study (PACORES) Group | British Journal of Ophthalmology
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy | BMC Ophthalmology | Full Text
Half-dose PDT outperforms subthreshold micropulse laser for central serous chorioretinopathy - American Academy of Ophthalmology
